Literature DB >> 12696211

Safe administration of oral chemotherapy.

Ann Birner1.   

Abstract

High standards of care are desirable for patients in any setting who receive chemotherapy by any route. Patients who self-administer oral chemotherapy are subject to risks of adverse effects similar to those who receive i.v. chemotherapy. Safeguards to prevent medication error in these patients may not be achieved to the same degree as for patients receiving i.v. drugs in an institutional setting. This article describes the differences between typical administration standards for i.v. chemotherapy versus oral chemotherapy. The process of oral chemotherapy provision is examined, with examples of drug characteristics and patient features important in each step. Recommendations are made for improving the care of patients receiving oral chemotherapy medications, particularly in the home setting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12696211     DOI: 10.1188/03.CJON.158-162

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  9 in total

1.  Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey.

Authors:  Sultan Kav; Humeyra Bostanci
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

2.  Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Authors:  Saul N Weingart; Jonathan Flug; Daniela Brouillard; Laurinda Morway; Ann Partridge; Sylvia Bartel; Lawrence N Shulman; Maureen Connor
Journal:  BMJ       Date:  2007-01-12

3.  Prescribing oral chemotherapy.

Authors:  Sandeep D Parsad; Mark J Ratain
Journal:  BMJ       Date:  2007-02-24

4.  Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial.

Authors:  C Riese; B Weiß; U Borges; A Beylich; R Dengler; K Hermes-Moll; M Welslau; W Baumann
Journal:  Support Care Cancer       Date:  2017-06-09       Impact factor: 3.603

5.  Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel.

Authors:  Susan Goodin; Niesha Griffith; Beth Chen; Karen Chuk; Mikael Daouphars; Christian Doreau; Rinku A Patel; Rowena Schwartz; Maria José Tamés; Robert Terkola; Barbara Vadnais; Debbie Wright; Klaus Meier
Journal:  J Oncol Pract       Date:  2011-01       Impact factor: 3.840

Review 6.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

Review 7.  Oral anticancer drugs in the elderly: an overview.

Authors:  Sara Lonardi; Alberto Bortolami; Micaela Stefani; Silvio Monfardini
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer.

Authors:  Ho-Suap Hahn; Ki-Heon Lee; In-Ho Lee; Jae-Ho Lee; Chang-Sung Whang; Yeong-Woo Jo; Tae-Jin Kim
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

9.  Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.

Authors:  Gennaro A Paolella; Andrew D Boyd; Scott M Wirth; Sandra Cuellar; Neeta K Venepalli; Stephanie Y Crawford
Journal:  Pharmacy (Basel)       Date:  2018-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.